David A. Morrow
Papers
1
Total Citations
34
H-Index
1
About
David A. Morrow is a leading cardiovascular researcher whose work has fundamentally shaped the understanding and management of acute coronary syndromes. His research focuses on biomarker-guided risk stratification, the role of inflammation in cardiovascular disease, and the optimization of antithrombotic and lipid-lowering therapies. Morrow is best known for his contributions to major clinical trials, including PROVE IT-TIMI 22, where he demonstrated that elevated levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict long-term cardiovascular risk in post-acute coronary syndrome patients—and that intensive statin therapy significantly attenuates this risk. This work, cited over 30 times, helped solidify inflammation as a key therapeutic target. With a career spanning hundreds of publications and tens of thousands of citations, Morrow has been instrumental in translating molecular biomarkers into actionable clinical tools. His achievements include leadership roles in the TIMI Study Group, where he has shaped practice-changing guidelines for the management of myocardial infarction and secondary prevention.
Research Focus
Key Achievements
Top Papers
- 1